In recently relapsed polymyalgia rheumatica during GC tapering, secukinumab increased sustained remission rates at 1 y.
Medicine
Abstract
CLINICAL IMPACT RATINGS GIM/FP/GP: [Formula: see text] Rheumatology: [Formula: see text].